The global ventral hernia treatment market garnered a market value of USD 4.75 billion in 2022 and is expected to accumulate a market value of USD 9.4 billion by registering a CAGR of 6.4% in the forecast period 2023 to 2033.
The growth of the ventral hernia treatment market can be attributed to the increasing incidence of ventral hernias, the rising demand for minimally invasive surgical procedures, the growing geriatric population, and the availability of technologically advanced products and services. The market for ventral hernia treatment registered a CAGR of 3.3% in the historical period 2018 to 2022
A ventral hernia is a condition where a portion of the intestines or other abdominal tissue pushes through a weakened area of the abdominal muscles, causing a bulge or protrusion on the skin's surface.
The treatment of ventral hernias includes surgical procedures like laparoscopic surgery, open surgery, and other minimally invasive techniques. The market for ventral hernia treatment includes medical devices, surgical equipment, pharmaceuticals, and other related products and services used in the diagnosis, treatment, and management of ventral hernias.
Report Attribute | Details |
---|---|
Expected Market Value (2023) | USD 5.05 Billion |
Anticipated Forecast Value (2033) | USD 9.4 Billion |
Projected Growth Rate (2023 to 2033) | 6.4% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Ventral hernia treatment reflected a value of 3.3% during the historical period, 2018 to 2022.
The growth was attributed to the increasing prevalence of ventral hernias, the rising demand for minimally invasive surgical procedures, and the availability of advanced hernia repair devices. Moreover, key players have been investing in research and development for innovating novel therapies for ventral hernia treatment. Thus, the market for ventral hernia treatment is expected to register a CAGR of 6.4% in the forecast period 2023 to 2033.
Growing preference for minimally invasive surgical procedures driving market growth
The prevalence of ventral hernias is increasing globally due to several factors such as obesity, aging population, and sedentary lifestyle. This has led to a rise in demand for hernia repair surgeries and related products and services.
The development of advanced hernia repair devices such as mesh implants, surgical staplers, and robotic-assisted surgical systems has improved the efficiency and safety of hernia repair surgeries, leading to increased adoption of these devices.
Minimally invasive surgical procedures, such as laparoscopic surgery, offer several advantages over traditional open surgeries, including reduced pain, faster recovery, and shorter hospital stays. This has led to a growing preference for minimally invasive procedures among patients and healthcare providers.
Awareness and education campaigns by healthcare organizations and governments have helped to increase public awareness about ventral hernias and their treatment options, leading to increased demand for hernia repair surgeries and related products and services.
The increasing healthcare spending globally, particularly in emerging markets, has led to increased access to healthcare services, including hernia repair surgeries and related products and services.
Availability of treatments shaping landscape for ventral hernias treatment market
High cost of treatment along with reimbursement issues derailing market growth for ventral hernia treatment market
The cost of hernia repair surgeries and related products and services can be high, particularly for uninsured or underinsured patients, which can limit access to care. In some countries, reimbursement policies for hernia repair surgeries may be inadequate, which can limit access to care and affect the demand for hernia repair devices and related products and services.
Despite efforts to increase awareness about hernias and their treatment options, many people may still be unaware of the condition, which can delay diagnosis and treatment. Like any surgical procedure, hernia repair surgeries carry risks of complications such as infection, bleeding, and nerve damage.
The ventral hernia treatment market is highly competitive, with several key players operating in the industry, which can make it difficult for new entrants to establish themselves and compete with established players. The ventral hernia treatment market is subject to various regulations and standards, which can affect the development and commercialization of hernia repair devices and related products and services.
Growing preference for minimally invasive surgeries driving market growth in North America
The North American ventral hernia treatment market is a significant market segment within the global hernia treatment market. North America is one of the largest markets for hernia treatment globally, and it includes the United States and Canada.
The increasing prevalence of obesity and an aging population in North America has contributed to the rising incidence of ventral hernias in the region. This, in turn, has led to an increase in demand for hernia repair surgeries and related products and services.
The North America ventral hernia treatment market is highly competitive, with several key players operating in the industry. These companies are investing heavily in research and development to develop advanced hernia repair devices and surgical techniques.
The market is also witnessing a growing preference for minimally invasive surgical procedures, such as laparoscopic surgery, over traditional open surgeries. This trend is driven by the benefits of minimally invasive procedures, including reduced pain, faster recovery, and shorter hospital stays.
Overall, the North America ventral hernia treatment market is expected to continue to grow in the coming years, driven by increasing awareness and education about hernias, advances in hernia repair devices and surgical techniques, and the rising incidence of ventral hernias in the region. Thus, North America is expected to possess a 46% market share for ventral hernia treatment market.
Rising demand for outpatient procedures bolstering growth of ventral hernia treatment market in Europe
The incidence of ventral hernias is increasing in Europe due to factors such as an aging population, sedentary lifestyles, and obesity. This has led to an increase in demand for hernia repair surgeries and related products and services.
The development of new and innovative hernia repair devices and surgical techniques is driving growth in the Europe ventral hernia treatment market. For example, the use of minimally invasive laparoscopic surgery techniques is increasing in popularity, as it is associated with faster recovery times and reduced pain compared to traditional open surgery.
There is a growing trend towards outpatient hernia repair surgeries in Europe. Outpatient surgeries are less expensive and more convenient for patients, which is driving growth in the ventral hernia treatment market. Many countries in Europe have favorable reimbursement policies for hernia repair surgeries, which is helping to drive growth in the ventral hernia treatment market.
There is growing awareness and education about hernias and their treatment options among healthcare providers and the general public in Europe, which is driving demand for hernia repair products and services. Thus, Europe is expected to possess a 38% market share for ventral hernia treatment market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Availability of specialized medical staff maximizing the use of hospitals for ventral hernia treatment
Hospitals have a team of specialized medical staff, including surgeons, anesthesiologists, and nurses, who are trained and experienced in treating ventral hernias. These healthcare professionals have the necessary skills and knowledge to provide effective hernia treatment and manage any complications that may arise during or after the procedure.
Hospitals are equipped with advanced technology and equipment that are necessary for performing hernia surgeries safely and effectively. This includes surgical instruments, imaging technology, and monitoring devices that help ensure the patient's safety and well-being during the procedure.
After hernia surgery, patients require ongoing care and monitoring to ensure proper healing and prevent complications. Hospitals provide a range of post-operative care services, including pain management, wound care, and physical therapy, that can help patients recover more quickly and with fewer complications.
In rare cases, hernia surgery can lead to complications that require emergency medical attention. Hospitals are equipped to handle emergencies and have the necessary resources to provide life-saving care if needed. Thus, hospitals are expected to possess a 48% market share for ventral hernia treatment market.
Key players in the ventral hernia treatment market are Medtronic, Becton Dickinson & Company, Braun Melsungen AG, Cook Medical Inc., Cooper Companies Inc., Baxter International, Inc., Integra LifeSciences, W.L. Gore & Associates, AbbVie, Johnson & Johnson Services, Inc.
Report Attribute | Details |
---|---|
Market Value in 2023 | USD 5.05 Billion |
Market Value in 2033 | USD 9.4 Billion |
Growth Rate | CAGR of 6.4% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in USD Billion and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered | Type, Diagnosis, Surgery Type, End Use, Region |
Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, United kingdom, France, Spain, Italy, India, Malaysia, Singapore, Thailand, China, Japan, South Korea, Austria, New Zealand, GCC countries, South Africa, Israel |
Key Companies Profiled | Medtronic; Becton Dickinson & Company; Braun Melsungen AG; Cook Medical Inc.; Cooper Companies Inc.; Baxter International, Inc.; Integra LifeSciences; W.L. Gore & Associates; AbbVie; Johnson & Johnson Services, Inc. |
Customization | Available Upon Request |
The industry is valued at USD 5.05 billion in 2023.
Ethicon, Bard, and Aesculap are key industry players.
The key consumer of the ventral hernia treatment market is the healthcare industry.
The industry is estimated to reach USD 9.4 billion by 2033.
The ventral hernia treatment market CAGR for 2033 is 6.4%.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Epigastric (stomach area) hernia 5.2. Umbilical (belly button) hernia 5.3. Incisional hernia 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Diagnosis 6.1. Ultrasound 6.2. CT scan 6.3. MRI 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Surgery Type 7.1. Open hernia surgery 7.2. Laparoscopic surgery 7.3. Robotic hernia surgery 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-use 8.1. Hospitals 8.2. Ambulatory Surgical Centres 8.3. Clinics 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 9.1. North America 9.2. Latin America 9.3. Europe 9.4. South Asia 9.5. East Asia 9.6. Oceania 9.7. MEA 10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Key Countries Market Analysis 18. Market Structure Analysis 19. Competition Analysis 19.1. Medtronic 19.2. Becton Dickinson & Company 19.3. B. Braun Melsungen AG 19.4. Cook Medical Inc. 19.5. Cooper Companies Inc. 19.6. Baxter International, Inc. 19.7. Integra LifeSciences 19.8. W.L. Gore & Associates 19.9. AbbVie 19.10. Johnson & Johnson Services, Inc. 20. Assumptions & Acronyms Used 21. Research Methodology
Explore Healthcare Insights
View Reports